Count on us for updates on the coronavirus and guidance for cancer patients and family members.Read the latest articles
Dr. Rafael Fonseca is a Hematologist and Oncologist, and is the interim director of the Mayo Clinic Cancer Center. He is the Getz Family Professor of Cancer and a Distinguished Mayo Investigator. He completed medical school at Anahuac University, followed by residency at the University of Miami. Dr. Fonseca completed a fellowship at the Mayo Graduate School of Medicine in Clinical Hematology and Medical Oncology. His research focuses on understanding the disease biology and genetic characteristics of plasma cell disorders. He is also interested in myeloma clinical trials, developing novel therapies and biomarkers for myeloma bone disease. He has a special interest in targeting reactive oxygen metabolic pathways as a way to treat myeloma. Dr. Fonseca’s research has helped guide the myeloma field in understanding patient risk markers and the progression of disease. He has received consulting from Amgen, BMS, Celgene, Takeda, Bayer, Jansen, Novartis, Pharmacyclics, Sanofi, AbbieVie and Merck. He is a member of the Scientific Advisory Board of Adaptive Biotechnologies.